Cecilia Martin assists the firm in patent prosecution in areas related to biotechnology. A PhD with postdoctoral training in neuroscience and endocrinology, Cecilia utilizes her extensive technological knowledge when assisting clients.
Prior to joining Wolf Greenfield, Cecilia was a Project Manager in the Biotechnology and Pharmaceutics Group at a research and intellectual property consulting firm. In addition, Cecilia spent a significant amount of time in the healthcare industry, assisting with research, intellectual property, and technology development at Mass General Brigham, Harvard Medical School, and Boston Children’s Hospital.
Cecilia has been published in leading journals such as Nature Reviews Drug Development and the New England Journal of Medicine.